Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Cardiotoxicity of doxorubicin (DOX) remains an important health concern. DOX cardiotoxicity is cumulative-dose-dependent and begins with the first dose of chemotherapy. No biomarker for presymptomatic detection of DOX cardiotoxicity has been validated. Our hypothesis is that peripheral blood cells (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Todorova, Valentina K., Makhoul, Issam, Siegel, Eric R., Wei, Jeanne, Stone, Annjanette, Carter, Weleetka, Beggs, Marjorie L., Owen, Aaron, Klimberg, V. Suzanne
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4973957/
https://ncbi.nlm.nih.gov/pubmed/27490685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0160224
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars